• LOGIN
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publication
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Diagnostic, research, and real-life effect of the 2023 EULAR-ACR classification criteria for antiphospholipid syndrome.
 

Diagnostic, research, and real-life effect of the 2023 EULAR-ACR classification criteria for antiphospholipid syndrome.

Options
  • Details
BORIS DOI
10.48620/87015
Date of Publication
May 2025
Publication Type
Article
Division/Institute

Clinic of Gynaecology...

Author
Schreiber, Karen
Aguilera, Silvia
Amengual, Olga
Cohen, Hannah
Castro Oliveira De Andrade, Danieli
Duarte-García, Alí
Gerosa, Maria
Nelson-Piercy, Catherine
Radin, Massimo
Raio, Luigi
Clinic of Gynaecology
Sciascia, Savino
Subject(s)

600 - Technology::610...

Series
The Lancet Rheumatology
ISSN or ISBN (if monograph)
2665-9913
Publisher
Elsevier
Language
English
Publisher DOI
10.1016/S2665-9913(24)00396-5
PubMed ID
40064187
Description
The role of classification criteria is particularly important in rheumatic diseases compared with other medical disorders, as the complexity and overlapping symptoms of these conditions make diagnosis challenging. Moreover, the absence of established diagnostic criteria further complicates diagnosing patients. Classification criteria can assist health-care professionals and patients as a diagnostic aid. However, classification criteria are developed for research purposes to standardise populations in clinical trials and observational studies of rheumatic diseases and not for diagnosing patients. Introduction of the 2023 American College of Rheumatology-European Alliance of Associations for Rheumatology (ACR-EULAR) antiphospholipid syndrome classification criteria underscores the important distinction between meeting these criteria and being diagnosed with the condition-a differentiation essential in both clinical practice and research. Although the 2023 ACR-EULAR antiphospholipid syndrome classification criteria improved precision in classification of pregnant individuals with antiphospholipid syndrome, which ultimately should lead to better outcomes and care for these patients, the updated criteria should not be used as diagnostic criteria in routine clinical practice. In this Personal View, we examine the possible effect of the 2023 ACR-EULAR antiphospholipid syndrome classification criteria, with a particular focus on the pregnancy-related aspects of the syndrome.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/206786
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
1-s2.0-S2665991324003965-main.pdftextAdobe PDF225.85 KBpublished restricted
BORIS Portal
Bern Open Repository and Information System
Build: d1c7f7 [27.06. 13:56]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo